The body determines where fat is stored and where it is lost based on factors such as: Genetics Hormones Age Overall body composition If someone loses weight while using BPC-157, there is no evidence suggesting the peptide specifically targets fat around the stomach
Finally, targeting angiogenesis and NOs cytotoxic and damaging actions but maintaining, promoting, or recovering their essential protective functions [3,4,5,6,7,8,9,10,11,12,13,14,16,17,18,19,20,21,22,23,24,27,28,29,30,31,32,34,37,39,40] could indicate cytoprotective evidence that aligns with BPC 157 as a neurotransmitter, as previously envisaged in the implementation of the cytoprotection effects [6,9] (i.e., a cytoprotection mediator holds a response specifically related to preventing or recovering damage as such)
For syringe-unit math, use the calculator linked at the bottom
What do they do
Confirmation of mutations in PROSC as a novel cause of vitamin B 6 -dependent epilepsy
Jin Q, Cirelli JA, Park CH, et al